Nelson Syndrome: Update on Therapeutic Approaches (Q38356171)

2 September 2017

1 reference

title

Nelson Syndrome: Update on Therapeutic Approaches (English)

1 reference

2 September 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683128%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Anand Veeravagu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683128%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sunny Kumar

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683128%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Laurence Katznelson

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683128%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

12 February 2015

1 reference

2 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683128%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683128%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683128%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

1135-1140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683128%20AND%20SRC:MED&resulttype=core&format=json

Management of recurrent and refractory Cushing disease

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

The Nelson's syndrome... revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Corticotroph tumor progression after adrenalectomy in Cushing's Disease: A reappraisal of Nelson's Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Nelson syndrome: comprehensive review of pathophysiology, diagnosis, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

The Effects of SOM230 on Cell Proliferation and Adrenocorticotropin Secretion in Human Corticotroph Pituitary Adenomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Approach to the Cushing's disease patient with persistent/recurrent hypercortisolism after pituitary surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

The molecular pathogenesis of corticotroph tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Medical management of persistent and recurrent cushing disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Chronic administration of corticotropin-releasing factor increases pituitary corticotroph number.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Radiation therapy in the treatment of pituitary tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Nelson's syndrome after bilateral adrenalectomy for Cushing's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Cabergoline monotherapy in the long-term treatment of Cushing's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

PPAR-gamma in Cushing's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Role of somatostatin receptors in normal and tumoral pituitary corticotropic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Incidence of Nelson's syndrome after adrenalectomy for Cushing's disease in children: results of a nationwide survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Megavoltage pituitary irradiation in the management of Cushing's disease and Nelson's syndrome: long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Bilateral adrenalectomy for Cushing's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

The effects of octreotide in a patient with Nelson's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Neurosurgical Treatment of Nelson’s Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Long-term treatment of Nelson's syndrome with sodium valproate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Management of Nelson's syndrome: observations in fifteen patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Comprehensive review of stereotactic radiosurgery for medically and surgically refractory pituitary adenomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Gamma knife radiosurgery for Cushing's disease and Nelson's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Gamma Knife surgery for adrenocorticotropic hormone-producing pituitary adenomas after bilateral adrenalectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Aspects of anterior pituitary growth, with special reference to corticotrophs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Effect of stereotactic radiosurgery before bilateral adrenalectomy for Cushing's disease on the incidence of Nelson's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Treatment of Nelson's syndrome with temozolomide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

The PPAR-gamma activator rosiglitazone fails to lower plasma ACTH levels in patients with Nelson's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Ineffectiveness of rosiglitazone therapy in Nelson's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Long-term results of total adrenalectomy for Cushing's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

ACTH-producing tumor of the pituitary gland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Evaluation and treatment of Cushing's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Favorable long-term outcomes of bilateral adrenalectomy in Cushing's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Late recurrences of Cushing's disease after initial successful transsphenoidal surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Long-term treatment of Nelson's syndrome by octreotide: a case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Dopamine receptor expression and function in corticotroph pituitary tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Effect of an oral serotonin antagonist, ketanserin, on plasma ACTH concentrations in Nelson's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

A physiologic approach to diagnosis of the Cushing syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Clinical review: Outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Low immunohistochemical expression of MGMT in ACTH secreting pituitary tumors of patients with Nelson syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Pathobiology of pituitary adenomas and carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Bilateral adrenalectomy for refractory Cushing disease: a safe and definitive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Effect of the serotonin antagonists ritanserin and ketanserin in Cushing's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Medical management of Cushing's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Management of Cushing disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Gamma knife stereotactic radiosurgery of Nelson syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Outcomes of proton therapy for patients with functional pituitary adenomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

Nelson's syndrome: single centre experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

The dose-response relationship of ACTH and cortisol in Cushing's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2015.01.038

10.1016/J.WNEU.2015.01.038

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683128%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference